Surging demand to propel Inter Pharma to sales goalSET-listed pharmaceutical and food supplement company Inter Pharma Plc expects to achieve its sales target of 2.5 billion baht in 2024, one year early thanks to the pandemic, which has accelerated demand for pharmaceutical and food supplements. "More people dare to spend their money on healthcare products. "We've seen an increasing growth momentum for food supplements, wellness and pharmaceutical products in the first half of this year. Apart from Covid-19, Mr Trinnawat said Thailand's ageing society will also spur demand for wellness products. The firm currently produces and markets five core product categories comprising pharmaceutical products; wellness and anti-ageing products; cosmeceuticals & aesthetic innovation products; companion animal healthcare products; and livestock animal healthcare products.

Source: Bangkok Post September 15, 2021 23:37 UTC